Alnylam Pharmaceuticals
ALNY
#563
Rank
S$53.58 B
Marketcap
S$404.04
Share price
-1.75%
Change (1 day)
24.27%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company